AMTI Gains 44.44%

AMTI (AMTI:NASDAQ) shot up at $63.57, representing a gain of 44.4%. On Wed 31 Mar 21, AMTI:NASDAQ hit a New 2-Week Intraday Low of $41.37. The stock appeared on our News Catalysts scanner on Wed 31 Mar 21 at 09:06 PM in the 'PUBLIC OFFERING' category. From Wed 17 Mar 21, the stock recorded 20.00% Up Days and 18.18% Green Days

About AMTI (AMTI:NASDAQ)

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.